Key facts
- This page summarizes Jon Halbert's Form 4 filing for Caris Life Sciences, Inc. (CAI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Aug 2026, 17:38.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
Footnote F2
Includes shares received in pro rata distributions exempt pursuant to Rule 16a-9.
Footnote F3
The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.